Meridian Bioscience, Inc. (VIVO) announced the company now expects non-GAAP net earnings for fiscal 2018 to be between $0.69 and $0.72 per share, an increase from the previously published range of $0.65 to $0.68. The company now expects revenues for the fiscal year ending September 30, 2018 of between $209 million to $214 million, compared to the previous guidance range of $207 million to $212 million.
On a non-GAAP basis, second-quarter earnings were $8.9 million, or $0.21 per diluted share, decreases of 5% each compared to the fiscal 2017 second quarter. Second-quarter net revenues were $56.5 million, up 4% from last year.
The Board of Directors declared the regular quarterly cash dividend of $0.125 per share for the second quarter ended March 31, 2018. The dividend is payable on May 17, 2018 to shareholders of record as of the close of business on May 7, 2018.
For comments and feedback contact: editorial@rttnews.com
Business News